Sponsor:
Baylor College of Medicine
Code:
NCT05318222
Conditions
Birth Defects
Multiple Congenital Anomaly
Neurodevelopmental Disorders
Eligibility Criteria
Sex: All
Age: 0 - 18
Healthy Volunteers: Accepted
Interventions
Whole genome sequencing (WGS)
Brief summary:
Conditions
Birth Defects
Multiple Congenital Anomaly
Neurodevelopmental Disorders
Study ID
NCT05318222
Start date
Jun 1, 2022
Status verified date
Sep, 2026
Completion date
Jan 31, 2027
Anticipated
Primary completion date
Jan 31, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 0 - 18
Healthy Volunteers: Accepted
Enrollment
200 participants
Anticipated
Intervention Model
Single group
Primary purpose
Diagnostic
Arms
other: WGS arm
Interventions
Whole genome sequencing (WGS)
Primary outcome measure
Central contacts
Locations
University of Texas Rio Grande Valley
Recruiting
Edinburg, Texas, United States, 78539
Contacts
Lori Berry, MD
lori.berry@utrgv.eduSponsor
Baylor College of Medicine
Last update posted
Oct 1, 2026
Last verified
Sep, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-25. This information was provided to ClinicalTrials.gov by Baylor College of Medicine on 2026-10-01. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.